Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cell Therapeutics
Cell Therapeutics
$4 Or Less: 2 Small Biotechs Moving On News
Seeking Alpha
Wed, 07/2/14 - 01:12 pm
Pixuvri
Agenus
Cell Therapeutics
Cell Therapeutics: Enticing To All, Convincing To None
Seeking Alpha
Wed, 05/7/14 - 09:54 am
Cell Therapeutics
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013
TheStreet.com
Tue, 01/21/14 - 09:37 am
biotech
Intercept Pharma
Rexahn
CorMedix
Neurocrine
Cell Therapeutics
Cell Therapeutics Regains Rights to Two In-Development Cancer Medicines
Wall St Cheat Sheet
Mon, 01/13/14 - 05:03 pm
Cell Therapeutics
Novartis
Opaxio
Pixuvri
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
JPMHC 2014
GSK
Intercept Pharma
Acorda Therapeutics
Cell Therapeutics
Novartis
Sanofi
Alnylam
Idenix
Alexion
Galena Biopharma
Incyte
Clovis Oncology
Dendreon
Merck
Arena Pharmaceuticals
Is Cell Therapeutics Turning Over A New Leaf In 2014?
Wall St Cheat Sheet
Mon, 01/6/14 - 11:51 am
Cell Therapeutics
tosedostat
FDA lifts hold on studies testing Cell Therapeutics' cancer drug
Reuters
Thu, 01/2/14 - 11:15 am
FDA
Cell Therapeutics
tosedostat
acute myeloid leukemia
Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
Motley Fool
Tue, 12/10/13 - 11:36 am
Verastem
Cell Therapeutics
Novartis
Geron
imetelstat
Jakavi
myelofibrosis
tosedostat
AML
VS-5584
Baxter, Cell Therapeutics announce collaboration to develop pacritinib
Yahoo/Fly on the Wall
Fri, 11/15/13 - 08:43 am
Baxter International
pacritinib
Cell Therapeutics
JAK2/FLT3 inhibitors
solid tumors
myelofibrosis
3 Humongous Health-Care Stocks This Week
Motley Fool
Sun, 10/13/13 - 12:08 pm
TherapeuticsMD
Aratana
Cell Therapeutics
Are These 2 High-Flying Biotech Stocks a Buy?
Motley Fool
Tue, 10/8/13 - 08:39 am
Cell Therapeutics
pacritinib
INSYS Therapeutics
Subsys
Cell Therapeutics raises $14.8M in convertible preferred stock sale
Yahoo/Fly on the Wall
Fri, 09/13/13 - 09:10 am
Cell Therapeutics
Cell Therapeutics' aggressive non-hodgkin lymphoma treatment wins market access in France
Pharmaceutical Business Review
Mon, 08/19/13 - 09:54 am
non-Hodgkin's lymphoma
France
Cell Therapeutics
Pixuvri
FDA puts Cell Therapeutics blood cancer drug on hold after death
Reuters
Mon, 06/24/13 - 11:01 am
FDA
Cell Therapeutics
tosedostat
leukemia
CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
Yahoo/PR Newswire
Sat, 06/1/13 - 12:13 pm
Brostallicin
breast cancer
Cell Therapeutics
Cell Therapeutics announces positive results from OPAL study of tosedostat
Yahoo/Fly on the Wall
Mon, 03/4/13 - 10:57 am
tosedostat
Cell Therapeutics
Chroma Therapeutics
AML
acute myeloid leukemia
German Institute for Quality and Efficiency in Health Care (IQWiG) Publishes Dossier Evaluation within Early Benefit Assessment Process of Pixuvri (pixantrone)
Yahoo/PR Newswire
Sat, 03/2/13 - 03:56 pm
Pixuvri
non-Hodgkin B-cell lymphoma
non-Hodgkin's lymphoma
Cell Therapeutics
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Motley Fool
Sun, 12/9/12 - 01:21 pm
Chelsea Therapeutics
Cell Therapeutics
Aeterna Zentaris
Progenics Pharmaceuticals
Aveo Pharmaceutical
Exelixis
CEO Gaffe of the Week: Cell Therapeutics
Motley Fool
Sat, 10/13/12 - 12:05 pm
Cell Therapeutics
Pages
1
2
3
4
5
6
7
8
9
next ›
last »